Target Gene/Pathway Pathway / Gene


Search results


No. KEGG PATHWAY
On map, Yellow: Drug target, Red: All disease-related
KEGG GENES KEGG DRUG DrugBank 指定難病告示番号
1 Adherens junction 💬
1件: SRC 💬 Saracatinib 💬 Saracatinib 3件:  6 , 89, 272 💬
2 Adipocytokine signaling pathway 💬
3件: CPT1A, CPT1B, CPT1C 💬 Perhexiline maleate 💬 Perhexiline 2件: 58, 272 💬
3 Adipocytokine signaling pathway 💬
3件: CPT1A, CPT1B, CPT1C 💬 Perhexiline 💬 Perhexiline 2件: 58, 272 💬
4 Adrenergic signaling in cardiomyocytes 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Perhexiline maleate 💬 Perhexiline 2件: 58, 272 💬
5 Adrenergic signaling in cardiomyocytes 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Perhexiline 💬 Perhexiline 2件: 58, 272 💬
6 Alcoholic liver disease 💬
3件: CPT1A, CPT1B, CPT1C 💬 Perhexiline maleate 💬 Perhexiline 2件: 58, 272 💬
7 Alcoholic liver disease 💬
3件: CPT1A, CPT1B, CPT1C 💬 Perhexiline 💬 Perhexiline 2件: 58, 272 💬
8 Aldosterone synthesis and secretion 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Perhexiline maleate 💬 Perhexiline 2件: 58, 272 💬
9 Aldosterone synthesis and secretion 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Perhexiline 💬 Perhexiline 2件: 58, 272 💬
10 Alzheimer disease 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Perhexiline maleate 💬 Perhexiline 2件: 58, 272 💬
11 Alzheimer disease 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Perhexiline 💬 Perhexiline 2件: 58, 272 💬
12 Amphetamine addiction 💬
2件: CACNA1C, CACNA1D 💬 Perhexiline maleate 💬 Perhexiline 2件: 58, 272 💬
13 Amphetamine addiction 💬
2件: CACNA1C, CACNA1D 💬 Perhexiline 💬 Perhexiline 2件: 58, 272 💬
14 AMPK signaling pathway 💬
3件: CPT1A, CPT1B, CPT1C 💬 Perhexiline maleate 💬 Perhexiline 2件: 58, 272 💬
15 AMPK signaling pathway 💬
3件: CPT1A, CPT1B, CPT1C 💬 Perhexiline 💬 Perhexiline 2件: 58, 272 💬
16 Arrhythmogenic right ventricular cardiomyopathy 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Perhexiline maleate 💬 Perhexiline 2件: 58, 272 💬
17 Arrhythmogenic right ventricular cardiomyopathy 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Perhexiline 💬 Perhexiline 2件: 58, 272 💬
18 Axon guidance 💬
2件: ABL1, SRC 💬 Saracatinib 💬 Saracatinib 3件:  6 , 89, 272 💬
19 Bacterial invasion of epithelial cells 💬
1件: SRC 💬 Saracatinib 💬 Saracatinib 3件:  6 , 89, 272 💬
20 Bladder cancer 💬
1件: MMP9 💬 Andecaliximab 💬 Andecaliximab 5件: 46, 96, 97, 272, 299 💬
21 Bladder cancer 💬
1件: SRC 💬 Saracatinib 💬 Saracatinib 3件:  6 , 89, 272 💬
22 C-type lectin receptor signaling pathway 💬
1件: SRC 💬 Saracatinib 💬 Saracatinib 3件:  6 , 89, 272 💬
23 Calcium signaling pathway 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Perhexiline maleate 💬 Perhexiline 2件: 58, 272 💬
24 Calcium signaling pathway 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Perhexiline 💬 Perhexiline 2件: 58, 272 💬
25 cAMP signaling pathway 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Perhexiline maleate 💬 Perhexiline 2件: 58, 272 💬
26 cAMP signaling pathway 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Perhexiline 💬 Perhexiline 2件: 58, 272 💬
27 Carbohydrate digestion and absorption 💬
1件: CACNA1D 💬 Perhexiline maleate 💬 Perhexiline 2件: 58, 272 💬
28 Carbohydrate digestion and absorption 💬
1件: CACNA1D 💬 Perhexiline 💬 Perhexiline 2件: 58, 272 💬
29 Cardiac muscle contraction 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Perhexiline maleate 💬 Perhexiline 2件: 58, 272 💬
30 Cardiac muscle contraction 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Perhexiline 💬 Perhexiline 2件: 58, 272 💬
31 Cell cycle 💬
1件: ABL1 💬 Saracatinib 💬 Saracatinib 3件:  6 , 89, 272 💬
32 Cellular senescence 💬
1件: CACNA1D 💬 Perhexiline maleate 💬 Perhexiline 2件: 58, 272 💬
33 Cellular senescence 💬
1件: CACNA1D 💬 Perhexiline 💬 Perhexiline 2件: 58, 272 💬
34 cGMP-PKG signaling pathway 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Perhexiline maleate 💬 Perhexiline 2件: 58, 272 💬
35 cGMP-PKG signaling pathway 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Perhexiline 💬 Perhexiline 2件: 58, 272 💬
36 Chemical carcinogenesis - reactive oxygen species 💬
2件: ABL1, SRC 💬 Saracatinib 💬 Saracatinib 3件:  6 , 89, 272 💬
37 Chemical carcinogenesis - receptor activation 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Perhexiline maleate 💬 Perhexiline 2件: 58, 272 💬
38 Chemical carcinogenesis - receptor activation 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Perhexiline 💬 Perhexiline 2件: 58, 272 💬
39 Chemical carcinogenesis - receptor activation 💬
1件: SRC 💬 Saracatinib 💬 Saracatinib 3件:  6 , 89, 272 💬
40 Chemokine signaling pathway 💬
1件: SRC 💬 Saracatinib 💬 Saracatinib 3件:  6 , 89, 272 💬
41 Cholinergic synapse 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Perhexiline maleate 💬 Perhexiline 2件: 58, 272 💬
42 Cholinergic synapse 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Perhexiline 💬 Perhexiline 2件: 58, 272 💬
43 Chronic myeloid leukemia 💬
1件: ABL1 💬 Saracatinib 💬 Saracatinib 3件:  6 , 89, 272 💬
44 Circadian entrainment 💬
2件: CACNA1C, CACNA1D 💬 Perhexiline maleate 💬 Perhexiline 2件: 58, 272 💬
45 Circadian entrainment 💬
2件: CACNA1C, CACNA1D 💬 Perhexiline 💬 Perhexiline 2件: 58, 272 💬
46 Cortisol synthesis and secretion 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Perhexiline maleate 💬 Perhexiline 2件: 58, 272 💬
47 Cortisol synthesis and secretion 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Perhexiline 💬 Perhexiline 2件: 58, 272 💬
48 Cushing syndrome 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Perhexiline maleate 💬 Perhexiline 2件: 58, 272 💬
49 Cushing syndrome 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Perhexiline 💬 Perhexiline 2件: 58, 272 💬
50 Cytokine-cytokine receptor interaction 💬
1件: ACVR1 💬 Fidrisertib 💬 Fidrisertib 1件: 272 💬
51 Cytokine-cytokine receptor interaction 💬
1件: ACVR1 💬 Zilurgisertib 💬 Zilurgisertib 1件: 272 💬
52 Diabetic cardiomyopathy 💬
2件: CPT1B, CPT2 💬 Perhexiline maleate 💬 Perhexiline 2件: 58, 272 💬
53 Diabetic cardiomyopathy 💬
2件: CPT1B, CPT2 💬 Perhexiline 💬 Perhexiline 2件: 58, 272 💬
54 Diabetic cardiomyopathy 💬
1件: MMP9 💬 Andecaliximab 💬 Andecaliximab 5件: 46, 96, 97, 272, 299 💬
55 Dilated cardiomyopathy 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Perhexiline maleate 💬 Perhexiline 2件: 58, 272 💬
56 Dilated cardiomyopathy 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Perhexiline 💬 Perhexiline 2件: 58, 272 💬
57 Dopaminergic synapse 💬
2件: CACNA1C, CACNA1D 💬 Perhexiline maleate 💬 Perhexiline 2件: 58, 272 💬
58 Dopaminergic synapse 💬
2件: CACNA1C, CACNA1D 💬 Perhexiline 💬 Perhexiline 2件: 58, 272 💬
59 Efferocytosis 💬
3件: CPT1A, CPT1B, CPT1C 💬 Perhexiline maleate 💬 Perhexiline 2件: 58, 272 💬
60 Efferocytosis 💬
3件: CPT1A, CPT1B, CPT1C 💬 Perhexiline 💬 Perhexiline 2件: 58, 272 💬
61 Endocytosis 💬
1件: SRC 💬 Saracatinib 💬 Saracatinib 3件:  6 , 89, 272 💬
62 Epithelial cell signaling in Helicobacter pylori infection 💬
1件: SRC 💬 Saracatinib 💬 Saracatinib 3件:  6 , 89, 272 💬
63 ErbB signaling pathway 💬
2件: ABL1, SRC 💬 Saracatinib 💬 Saracatinib 3件:  6 , 89, 272 💬
64 Estrogen signaling pathway 💬
1件: MMP9 💬 Andecaliximab 💬 Andecaliximab 5件: 46, 96, 97, 272, 299 💬
65 Estrogen signaling pathway 💬
1件: SRC 💬 Saracatinib 💬 Saracatinib 3件:  6 , 89, 272 💬
66 Fatty acid degradation 💬
4件: CPT1A, CPT1B, CPT1C, CPT2 💬 Perhexiline maleate 💬 Perhexiline 2件: 58, 272 💬
67 Fatty acid degradation 💬
4件: CPT1A, CPT1B, CPT1C, CPT2 💬 Perhexiline 💬 Perhexiline 2件: 58, 272 💬
68 Fluid shear stress and atherosclerosis 💬
1件: ACVR1 💬 Fidrisertib 💬 Fidrisertib 1件: 272 💬
69 Fluid shear stress and atherosclerosis 💬
1件: ACVR1 💬 Zilurgisertib 💬 Zilurgisertib 1件: 272 💬
70 Fluid shear stress and atherosclerosis 💬
1件: MMP9 💬 Andecaliximab 💬 Andecaliximab 5件: 46, 96, 97, 272, 299 💬
71 Fluid shear stress and atherosclerosis 💬
1件: SRC 💬 Saracatinib 💬 Saracatinib 3件:  6 , 89, 272 💬
72 Focal adhesion 💬
1件: SRC 💬 Saracatinib 💬 Saracatinib 3件:  6 , 89, 272 💬
73 GABAergic synapse 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Perhexiline maleate 💬 Perhexiline 2件: 58, 272 💬
74 GABAergic synapse 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Perhexiline 💬 Perhexiline 2件: 58, 272 💬
75 GABAergic synapse 💬
16件: GABRA, GABRA, GABRA, GABRA, GABRA, GABRA, GABRB, GABRB, GABRB, GABRD, GABRE, GABRG, GABRG, GABRG, GABRP, GABRQ 💬 Midazolam maleate 💬 Midazolam 13件:  2 ,  3 ,  6 , 13, 21, 46, 67, 96, 97, 231, 272, 298, 299 💬
76 GABAergic synapse 💬
16件: GABRA, GABRA, GABRA, GABRA, GABRA, GABRA, GABRB, GABRB, GABRB, GABRD, GABRE, GABRG, GABRG, GABRG, GABRP, GABRQ 💬 Midazolam 💬 Midazolam 13件:  2 ,  3 ,  6 , 13, 21, 46, 67, 96, 97, 231, 272, 298, 299 💬
77 GABAergic synapse 💬
16件: GABRA, GABRA, GABRA, GABRA, GABRA, GABRA, GABRB, GABRB, GABRB, GABRD, GABRE, GABRG, GABRG, GABRG, GABRP, GABRQ 💬 Midazolam hydrochloride 💬 Midazolam 13件:  2 ,  3 ,  6 , 13, 21, 46, 67, 96, 97, 231, 272, 298, 299 💬
78 GABAergic synapse 💬
1件: SRC 💬 Saracatinib 💬 Saracatinib 3件:  6 , 89, 272 💬
79 Gap junction 💬
1件: SRC 💬 Saracatinib 💬 Saracatinib 3件:  6 , 89, 272 💬
80 Glucagon signaling pathway 💬
3件: CPT1A, CPT1B, CPT1C 💬 Perhexiline maleate 💬 Perhexiline 2件: 58, 272 💬
81 Glucagon signaling pathway 💬
3件: CPT1A, CPT1B, CPT1C 💬 Perhexiline 💬 Perhexiline 2件: 58, 272 💬
82 Glutamatergic synapse 💬
2件: CACNA1C, CACNA1D 💬 Perhexiline maleate 💬 Perhexiline 2件: 58, 272 💬
83 Glutamatergic synapse 💬
2件: CACNA1C, CACNA1D 💬 Perhexiline 💬 Perhexiline 2件: 58, 272 💬
84 GnRH secretion 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Perhexiline maleate 💬 Perhexiline 2件: 58, 272 💬
85 GnRH secretion 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Perhexiline 💬 Perhexiline 2件: 58, 272 💬
86 GnRH signaling pathway 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Perhexiline maleate 💬 Perhexiline 2件: 58, 272 💬
87 GnRH signaling pathway 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Perhexiline 💬 Perhexiline 2件: 58, 272 💬
88 GnRH signaling pathway 💬
1件: SRC 💬 Saracatinib 💬 Saracatinib 3件:  6 , 89, 272 💬
89 Growth hormone synthesis, secretion and action 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Perhexiline maleate 💬 Perhexiline 2件: 58, 272 💬
90 Growth hormone synthesis, secretion and action 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Perhexiline 💬 Perhexiline 2件: 58, 272 💬
91 Hepatitis B 💬
1件: MMP9 💬 Andecaliximab 💬 Andecaliximab 5件: 46, 96, 97, 272, 299 💬
92 Hepatitis B 💬
1件: SRC 💬 Saracatinib 💬 Saracatinib 3件:  6 , 89, 272 💬
93 Herpes simplex virus 1 infection 💬
1件: SRC 💬 Saracatinib 💬 Saracatinib 3件:  6 , 89, 272 💬
94 Hormone signaling 💬
1件: ACVR1 💬 Fidrisertib 💬 Fidrisertib 1件: 272 💬
95 Hormone signaling 💬
1件: ACVR1 💬 Zilurgisertib 💬 Zilurgisertib 1件: 272 💬
96 Hormone signaling 💬
1件: SRC 💬 Saracatinib 💬 Saracatinib 3件:  6 , 89, 272 💬
97 Human cytomegalovirus infection 💬
1件: SRC 💬 Saracatinib 💬 Saracatinib 3件:  6 , 89, 272 💬
98 Hypertrophic cardiomyopathy 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Perhexiline maleate 💬 Perhexiline 2件: 58, 272 💬
99 Hypertrophic cardiomyopathy 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Perhexiline 💬 Perhexiline 2件: 58, 272 💬
100 IL-17 signaling pathway 💬
1件: MMP9 💬 Andecaliximab 💬 Andecaliximab 5件: 46, 96, 97, 272, 299 💬
101 Inflammatory mediator regulation of TRP channels 💬
1件: SRC 💬 Saracatinib 💬 Saracatinib 3件:  6 , 89, 272 💬
102 Insulin resistance 💬
2件: CPT1A, CPT1B 💬 Perhexiline maleate 💬 Perhexiline 2件: 58, 272 💬
103 Insulin resistance 💬
2件: CPT1A, CPT1B 💬 Perhexiline 💬 Perhexiline 2件: 58, 272 💬
104 Insulin secretion 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Perhexiline maleate 💬 Perhexiline 2件: 58, 272 💬
105 Insulin secretion 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Perhexiline 💬 Perhexiline 2件: 58, 272 💬
106 Kaposi sarcoma-associated herpesvirus infection 💬
1件: SRC 💬 Saracatinib 💬 Saracatinib 3件:  6 , 89, 272 💬
107 Leukocyte transendothelial migration 💬
1件: MMP9 💬 Andecaliximab 💬 Andecaliximab 5件: 46, 96, 97, 272, 299 💬
108 Lipid and atherosclerosis 💬
1件: MMP9 💬 Andecaliximab 💬 Andecaliximab 5件: 46, 96, 97, 272, 299 💬
109 Lipid and atherosclerosis 💬
1件: SRC 💬 Saracatinib 💬 Saracatinib 3件:  6 , 89, 272 💬
110 Long-term potentiation 💬
1件: CACNA1C 💬 Perhexiline maleate 💬 Perhexiline 2件: 58, 272 💬
111 Long-term potentiation 💬
1件: CACNA1C 💬 Perhexiline 💬 Perhexiline 2件: 58, 272 💬
112 MAPK signaling pathway 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Perhexiline maleate 💬 Perhexiline 2件: 58, 272 💬
113 MAPK signaling pathway 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Perhexiline 💬 Perhexiline 2件: 58, 272 💬
114 MicroRNAs in cancer 💬
1件: ABL1 💬 Saracatinib 💬 Saracatinib 3件:  6 , 89, 272 💬
115 MicroRNAs in cancer 💬
1件: MMP9 💬 Andecaliximab 💬 Andecaliximab 5件: 46, 96, 97, 272, 299 💬
116 Mitophagy - animal 💬
1件: SRC 💬 Saracatinib 💬 Saracatinib 3件:  6 , 89, 272 💬
117 Morphine addiction 💬
16件: GABRA, GABRA, GABRA, GABRA, GABRA, GABRA, GABRB, GABRB, GABRB, GABRD, GABRE, GABRG, GABRG, GABRG, GABRP, GABRQ 💬 Midazolam 💬 Midazolam 13件:  2 ,  3 ,  6 , 13, 21, 46, 67, 96, 97, 231, 272, 298, 299 💬
118 Morphine addiction 💬
16件: GABRA, GABRA, GABRA, GABRA, GABRA, GABRA, GABRB, GABRB, GABRB, GABRD, GABRE, GABRG, GABRG, GABRG, GABRP, GABRQ 💬 Midazolam maleate 💬 Midazolam 13件:  2 ,  3 ,  6 , 13, 21, 46, 67, 96, 97, 231, 272, 298, 299 💬
119 Morphine addiction 💬
16件: GABRA, GABRA, GABRA, GABRA, GABRA, GABRA, GABRB, GABRB, GABRB, GABRD, GABRE, GABRG, GABRG, GABRG, GABRP, GABRQ 💬 Midazolam hydrochloride 💬 Midazolam 13件:  2 ,  3 ,  6 , 13, 21, 46, 67, 96, 97, 231, 272, 298, 299 💬
120 Neuroactive ligand signaling 💬
16件: GABRA, GABRA, GABRA, GABRA, GABRA, GABRA, GABRB, GABRB, GABRB, GABRD, GABRE, GABRG, GABRG, GABRG, GABRP, GABRQ 💬 Midazolam 💬 Midazolam 13件:  2 ,  3 ,  6 , 13, 21, 46, 67, 96, 97, 231, 272, 298, 299 💬
121 Neuroactive ligand signaling 💬
16件: GABRA, GABRA, GABRA, GABRA, GABRA, GABRA, GABRB, GABRB, GABRB, GABRD, GABRE, GABRG, GABRG, GABRG, GABRP, GABRQ 💬 Midazolam hydrochloride 💬 Midazolam 13件:  2 ,  3 ,  6 , 13, 21, 46, 67, 96, 97, 231, 272, 298, 299 💬
122 Neuroactive ligand signaling 💬
16件: GABRA, GABRA, GABRA, GABRA, GABRA, GABRA, GABRB, GABRB, GABRB, GABRD, GABRE, GABRG, GABRG, GABRG, GABRP, GABRQ 💬 Midazolam maleate 💬 Midazolam 13件:  2 ,  3 ,  6 , 13, 21, 46, 67, 96, 97, 231, 272, 298, 299 💬
123 Neuroactive ligand-receptor interaction 💬
16件: GABRA, GABRA, GABRA, GABRA, GABRA, GABRA, GABRB, GABRB, GABRB, GABRD, GABRE, GABRG, GABRG, GABRG, GABRP, GABRQ 💬 Midazolam hydrochloride 💬 Midazolam 13件:  2 ,  3 ,  6 , 13, 21, 46, 67, 96, 97, 231, 272, 298, 299 💬
124 Neuroactive ligand-receptor interaction 💬
16件: GABRA, GABRA, GABRA, GABRA, GABRA, GABRA, GABRB, GABRB, GABRB, GABRD, GABRE, GABRG, GABRG, GABRG, GABRP, GABRQ 💬 Midazolam 💬 Midazolam 13件:  2 ,  3 ,  6 , 13, 21, 46, 67, 96, 97, 231, 272, 298, 299 💬
125 Neuroactive ligand-receptor interaction 💬
16件: GABRA, GABRA, GABRA, GABRA, GABRA, GABRA, GABRB, GABRB, GABRB, GABRD, GABRE, GABRG, GABRG, GABRG, GABRP, GABRQ 💬 Midazolam maleate 💬 Midazolam 13件:  2 ,  3 ,  6 , 13, 21, 46, 67, 96, 97, 231, 272, 298, 299 💬
126 Neurotrophin signaling pathway 💬
1件: ABL1 💬 Saracatinib 💬 Saracatinib 3件:  6 , 89, 272 💬
127 Neutrophil extracellular trap formation 💬
1件: SRC 💬 Saracatinib 💬 Saracatinib 3件:  6 , 89, 272 💬
128 Nicotine addiction 💬
16件: GABRA, GABRA, GABRA, GABRA, GABRA, GABRA, GABRB, GABRB, GABRB, GABRD, GABRE, GABRG, GABRG, GABRG, GABRP, GABRQ 💬 Midazolam 💬 Midazolam 13件:  2 ,  3 ,  6 , 13, 21, 46, 67, 96, 97, 231, 272, 298, 299 💬
129 Nicotine addiction 💬
16件: GABRA, GABRA, GABRA, GABRA, GABRA, GABRA, GABRB, GABRB, GABRB, GABRD, GABRE, GABRG, GABRG, GABRG, GABRP, GABRQ 💬 Midazolam hydrochloride 💬 Midazolam 13件:  2 ,  3 ,  6 , 13, 21, 46, 67, 96, 97, 231, 272, 298, 299 💬
130 Nicotine addiction 💬
16件: GABRA, GABRA, GABRA, GABRA, GABRA, GABRA, GABRB, GABRB, GABRB, GABRD, GABRE, GABRG, GABRG, GABRG, GABRP, GABRQ 💬 Midazolam maleate 💬 Midazolam 13件:  2 ,  3 ,  6 , 13, 21, 46, 67, 96, 97, 231, 272, 298, 299 💬
131 Oxytocin signaling pathway 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Perhexiline maleate 💬 Perhexiline 2件: 58, 272 💬
132 Oxytocin signaling pathway 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Perhexiline 💬 Perhexiline 2件: 58, 272 💬
133 Oxytocin signaling pathway 💬
1件: SRC 💬 Saracatinib 💬 Saracatinib 3件:  6 , 89, 272 💬
134 Pathogenic Escherichia coli infection 💬
2件: ABL1, SRC 💬 Saracatinib 💬 Saracatinib 3件:  6 , 89, 272 💬
135 Pathways in cancer 💬
1件: ABL1 💬 Saracatinib 💬 Saracatinib 3件:  6 , 89, 272 💬
136 Pathways in cancer 💬
1件: MMP9 💬 Andecaliximab 💬 Andecaliximab 5件: 46, 96, 97, 272, 299 💬
137 Pathways of neurodegeneration - multiple diseases 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Perhexiline maleate 💬 Perhexiline 2件: 58, 272 💬
138 Pathways of neurodegeneration - multiple diseases 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Perhexiline 💬 Perhexiline 2件: 58, 272 💬
139 Platelet activation 💬
1件: SRC 💬 Saracatinib 💬 Saracatinib 3件:  6 , 89, 272 💬
140 PPAR signaling pathway 💬
4件: CPT1A, CPT1B, CPT1C, CPT2 💬 Perhexiline maleate 💬 Perhexiline 2件: 58, 272 💬
141 PPAR signaling pathway 💬
4件: CPT1A, CPT1B, CPT1C, CPT2 💬 Perhexiline 💬 Perhexiline 2件: 58, 272 💬
142 Prion disease 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Perhexiline maleate 💬 Perhexiline 2件: 58, 272 💬
143 Prion disease 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Perhexiline 💬 Perhexiline 2件: 58, 272 💬
144 Prolactin signaling pathway 💬
1件: SRC 💬 Saracatinib 💬 Saracatinib 3件:  6 , 89, 272 💬
145 Prostate cancer 💬
1件: MMP9 💬 Andecaliximab 💬 Andecaliximab 5件: 46, 96, 97, 272, 299 💬
146 Proteoglycans in cancer 💬
1件: MMP9 💬 Andecaliximab 💬 Andecaliximab 5件: 46, 96, 97, 272, 299 💬
147 Proteoglycans in cancer 💬
1件: SRC 💬 Saracatinib 💬 Saracatinib 3件:  6 , 89, 272 💬
148 Rap1 signaling pathway 💬
1件: SRC 💬 Saracatinib 💬 Saracatinib 3件:  6 , 89, 272 💬
149 Ras signaling pathway 💬
1件: ABL1 💬 Saracatinib 💬 Saracatinib 3件:  6 , 89, 272 💬
150 Regulation of actin cytoskeleton 💬
1件: SRC 💬 Saracatinib 💬 Saracatinib 3件:  6 , 89, 272 💬
151 Relaxin signaling pathway 💬
1件: MMP9 💬 Andecaliximab 💬 Andecaliximab 5件: 46, 96, 97, 272, 299 💬
152 Relaxin signaling pathway 💬
1件: SRC 💬 Saracatinib 💬 Saracatinib 3件:  6 , 89, 272 💬
153 Renin secretion 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Perhexiline maleate 💬 Perhexiline 2件: 58, 272 💬
154 Renin secretion 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Perhexiline 💬 Perhexiline 2件: 58, 272 💬
155 Retrograde endocannabinoid signaling 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Perhexiline maleate 💬 Perhexiline 2件: 58, 272 💬
156 Retrograde endocannabinoid signaling 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Perhexiline 💬 Perhexiline 2件: 58, 272 💬
157 Retrograde endocannabinoid signaling 💬
16件: GABRA, GABRA, GABRA, GABRA, GABRA, GABRA, GABRB, GABRB, GABRB, GABRD, GABRE, GABRG, GABRG, GABRG, GABRP, GABRQ 💬 Midazolam 💬 Midazolam 13件:  2 ,  3 ,  6 , 13, 21, 46, 67, 96, 97, 231, 272, 298, 299 💬
158 Retrograde endocannabinoid signaling 💬
16件: GABRA, GABRA, GABRA, GABRA, GABRA, GABRA, GABRB, GABRB, GABRB, GABRD, GABRE, GABRG, GABRG, GABRG, GABRP, GABRQ 💬 Midazolam hydrochloride 💬 Midazolam 13件:  2 ,  3 ,  6 , 13, 21, 46, 67, 96, 97, 231, 272, 298, 299 💬
159 Retrograde endocannabinoid signaling 💬
16件: GABRA, GABRA, GABRA, GABRA, GABRA, GABRA, GABRB, GABRB, GABRB, GABRD, GABRE, GABRG, GABRG, GABRG, GABRP, GABRQ 💬 Midazolam maleate 💬 Midazolam 13件:  2 ,  3 ,  6 , 13, 21, 46, 67, 96, 97, 231, 272, 298, 299 💬
160 Serotonergic synapse 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Perhexiline maleate 💬 Perhexiline 2件: 58, 272 💬
161 Serotonergic synapse 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Perhexiline 💬 Perhexiline 2件: 58, 272 💬
162 Serotonergic synapse 💬
3件: GABRB, GABRB, GABRB 💬 Midazolam maleate 💬 Midazolam 13件:  2 ,  3 ,  6 , 13, 21, 46, 67, 96, 97, 231, 272, 298, 299 💬
163 Serotonergic synapse 💬
3件: GABRB, GABRB, GABRB 💬 Midazolam 💬 Midazolam 13件:  2 ,  3 ,  6 , 13, 21, 46, 67, 96, 97, 231, 272, 298, 299 💬
164 Serotonergic synapse 💬
3件: GABRB, GABRB, GABRB 💬 Midazolam hydrochloride 💬 Midazolam 13件:  2 ,  3 ,  6 , 13, 21, 46, 67, 96, 97, 231, 272, 298, 299 💬
165 Shigellosis 💬
1件: SRC 💬 Saracatinib 💬 Saracatinib 3件:  6 , 89, 272 💬
166 Signaling pathways regulating pluripotency of stem cells 💬
1件: ACVR1 💬 Fidrisertib 💬 Fidrisertib 1件: 272 💬
167 Signaling pathways regulating pluripotency of stem cells 💬
1件: ACVR1 💬 Zilurgisertib 💬 Zilurgisertib 1件: 272 💬
168 Taste transduction 💬
1件: CACNA1C 💬 Perhexiline maleate 💬 Perhexiline 2件: 58, 272 💬
169 Taste transduction 💬
1件: CACNA1C 💬 Perhexiline 💬 Perhexiline 2件: 58, 272 💬
170 Taste transduction 💬
6件: GABRA, GABRA, GABRA, GABRA, GABRA, GABRA 💬 Midazolam maleate 💬 Midazolam 13件:  2 ,  3 ,  6 , 13, 21, 46, 67, 96, 97, 231, 272, 298, 299 💬
171 Taste transduction 💬
6件: GABRA, GABRA, GABRA, GABRA, GABRA, GABRA 💬 Midazolam 💬 Midazolam 13件:  2 ,  3 ,  6 , 13, 21, 46, 67, 96, 97, 231, 272, 298, 299 💬
172 Taste transduction 💬
6件: GABRA, GABRA, GABRA, GABRA, GABRA, GABRA 💬 Midazolam hydrochloride 💬 Midazolam 13件:  2 ,  3 ,  6 , 13, 21, 46, 67, 96, 97, 231, 272, 298, 299 💬
173 TGF-beta signaling pathway 💬
1件: ACVR1 💬 Fidrisertib 💬 Fidrisertib 1件: 272 💬
174 TGF-beta signaling pathway 💬
1件: ACVR1 💬 Zilurgisertib 💬 Zilurgisertib 1件: 272 💬
175 Thermogenesis 💬
4件: CPT1A, CPT1B, CPT1C, CPT2 💬 Perhexiline maleate 💬 Perhexiline 2件: 58, 272 💬
176 Thermogenesis 💬
4件: CPT1A, CPT1B, CPT1C, CPT2 💬 Perhexiline 💬 Perhexiline 2件: 58, 272 💬
177 Thyroid hormone signaling pathway 💬
1件: SRC 💬 Saracatinib 💬 Saracatinib 3件:  6 , 89, 272 💬
178 Tight junction 💬
1件: CACNA1D 💬 Perhexiline maleate 💬 Perhexiline 2件: 58, 272 💬
179 Tight junction 💬
1件: CACNA1D 💬 Perhexiline 💬 Perhexiline 2件: 58, 272 💬
180 Tight junction 💬
1件: SRC 💬 Saracatinib 💬 Saracatinib 3件:  6 , 89, 272 💬
181 TNF signaling pathway 💬
1件: MMP9 💬 Andecaliximab 💬 Andecaliximab 5件: 46, 96, 97, 272, 299 💬
182 Transcriptional misregulation in cancer 💬
1件: MMP9 💬 Andecaliximab 💬 Andecaliximab 5件: 46, 96, 97, 272, 299 💬
183 Tuberculosis 💬
1件: SRC 💬 Saracatinib 💬 Saracatinib 3件:  6 , 89, 272 💬
184 Type II diabetes mellitus 💬
2件: CACNA1C, CACNA1D 💬 Perhexiline maleate 💬 Perhexiline 2件: 58, 272 💬
185 Type II diabetes mellitus 💬
2件: CACNA1C, CACNA1D 💬 Perhexiline 💬 Perhexiline 2件: 58, 272 💬
186 Vascular smooth muscle contraction 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Perhexiline maleate 💬 Perhexiline 2件: 58, 272 💬
187 Vascular smooth muscle contraction 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Perhexiline 💬 Perhexiline 2件: 58, 272 💬
188 VEGF signaling pathway 💬
1件: SRC 💬 Saracatinib 💬 Saracatinib 3件:  6 , 89, 272 💬
189 Viral carcinogenesis 💬
1件: SRC 💬 Saracatinib 💬 Saracatinib 3件:  6 , 89, 272 💬
190 Viral myocarditis 💬
1件: ABL1 💬 Saracatinib 💬 Saracatinib 3件:  6 , 89, 272 💬
191 Yersinia infection 💬
1件: SRC 💬 Saracatinib 💬 Saracatinib 3件:  6 , 89, 272 💬